Skip to content
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•65 filings

TARS

Tarsus Pharmaceuticals, Inc.

Net sales of $5.2M over the last 3 months

4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.

How to read this signal

Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.

JSON example

3-month balance

−$5,192,759

0 buyers · 4 sellers

12-month purchases

$0.00

0 distinct insiders

12-month sales

$12,676,834

6 distinct insiders

Highlighted alerts

3

36 Rule 10b5-1 trades treated as informational

Buying cluster · 30 days

Fewer than three distinct buyers

CEO/CFO purchases · 12 months

No executive purchases found

Get TARS insider trades by API

The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.

Get your free API key

TARS overview: breakout setup, X sentiment and insiders in one page →

Form 4 raw → Raspberry

The value is in what we do not call a signal.

The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.

100
Raw transactions
Everything returned by the filing
39
Voluntary view
P/S trades after deterministic checks
77
Administrative noise
Stored, never alerted
25
10b5-1
Shown as informational
SEC ownership XML facts
Code
S
Shares
14,396
Price
$60.95
Footnotes
4

The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.

Raspberry interpretation
Informational — no alert

Reason: tax_withholding. The filing footnotes identify tax withholding.

Verify in SEC EDGAR

Recent transactions

Voluntary purchases and sales; administrative noise stays hidden.

39 transactions

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
66
Price
$80.01
Value
$5,281
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
759
Price
$79.00
Value
$59,961
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
11,675
Price
$78.33
Value
$914,503
Open SEC filing

Lin Elizabeth Yeu

Chief Medical Officer

Sale 10b5-1
Shares
1,590
Price
$90.00
Value
$143,100
Open SEC filing

Lin Elizabeth Yeu

Chief Medical Officer

Sale 10b5-1
Shares
1,590
Price
$85.00
Value
$135,150
Open SEC filing

Lin Elizabeth Yeu

Chief Medical Officer

Sale 10b5-1
Shares
5,386
Price
$90.00
Value
$484,740
Open SEC filing

Lin Elizabeth Yeu

Chief Medical Officer

Sale 10b5-1
Shares
5,387
Price
$85.00
Value
$457,895
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
2,900
Price
$91.27
Value
$264,683
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
7,100
Price
$90.27
Value
$640,917
Open SEC filing

Neervannan Seshadri

Chief Operating Officer

Sale 10b5-1
Shares
4,564
Price
$85.00
Value
$387,940
Open SEC filing

Lin Elizabeth Yeu

Chief Medical Officer

Sale 10b5-1
Shares
1,590
Price
$80.00
Value
$127,200
Open SEC filing

Lin Elizabeth Yeu

Chief Medical Officer

Sale 10b5-1
Shares
5,387
Price
$80.00
Value
$430,960
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
10,000
Price
$80.06
Value
$800,600
Open SEC filing

Lin Elizabeth Yeu

Chief Medical Officer

Sale 10b5-1
Shares
4,601
Price
$73.86
Value
$339,830
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
5,418
Price
$61.81
Value
$334,887
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
4,582
Price
$61.24
Value
$280,602
Open SEC filing

Goodrich Katherine

Director

Sale 10b5-1
Shares
2,954
Price
$62.08
Value
$183,384
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
1,928
Price
$62.94
Value
$121,348
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
10,572
Price
$61.97
Value
$655,147
Open SEC filing

Neervannan Seshadri

Chief Operating Officer

Sale 10b5-1
Shares
2,989
Price
$66.75
Value
$199,516
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
493
Price
$69.75
Value
$34,387
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
8,378
Price
$69.03
Value
$578,333
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
3,629
Price
$68.09
Value
$247,099
Open SEC filing

Neervannan Seshadri

Chief Operating Officer

Sale 10b5-1
Shares
8,366
Price
$76.67
Value
$641,421
Open SEC filing

Whitfield Dianne C.

Chief Human Resources Officer

Sale 10b5-1
Shares
893
Price
$82.93
Value
$74,056
Open SEC filing

Whitfield Dianne C.

Chief Human Resources Officer

Sale 10b5-1
Shares
835
Price
$81.90
Value
$68,387
Open SEC filing

Whitfield Dianne C.

Chief Human Resources Officer

Sale 10b5-1
Shares
8,122
Price
$80.71
Value
$655,527
Open SEC filing

Whitfield Dianne C.

Chief Human Resources Officer

Sale 10b5-1
Shares
5,715
Price
$80.09
Value
$457,714
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
557
Price
$83.54
Value
$46,532
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
5,443
Price
$82.41
Value
$448,558
Open SEC filing

Whitfield Dianne C.

Chief Human Resources Officer

Sale 10b5-1
Shares
7,397
Price
$80.10
Value
$592,500
Open SEC filing

LINK WILLIAM J PHD

Director

SaleAlert
Shares
4,766
Price
$81.50
Value
$388,429
Open SEC filing

LINK WILLIAM J PHD

Director

SaleAlert
Shares
5,680
Price
$80.71
Value
$458,433
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
1,148
Price
$82.39
Value
$94,584
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
6,306
Price
$81.75
Value
$515,516
Open SEC filing

LINK WILLIAM J PHD

Director

Sale 10b5-1
Shares
5,046
Price
$80.80
Value
$407,717
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
6,000
Price
$55.37
Value
$332,220
Open SEC filing

LINK WILLIAM J PHD

Director

SaleAlert
Shares
27,116
Price
$57.00
Value
$1,545,612
Open SEC filing

Azamian Bobak R.

President/CEO and Board Chair

Sale 10b5-1
Shares
6,000
Price
$50.00
Value
$300,000
Open SEC filing

“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.